Efter igangsættelse af behandling med pioglitazon anbefales det, at leverenzymer monitoreres med jævne mellemrum baseret på en klinisk vurdering.
Following initiation of therapy with pioglitazone, it is recommended that liver enzymes be monitored periodically based on clinical judgement.